Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035129 | PMC |
| http://dx.doi.org/10.1186/s13046-023-02643-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metabolomics combined with network pharmacology reveals the protective effect of astragaloside IV on alcoholic liver disease.
Phytomedicine
December 2024
School of Pharmaceutical Science, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan 030001, China. Electronic address:
Background: Alcoholic liver disease (ALD) is a significant contributor to liver damage. However, the clinical options for the treatment of ALD are limited. Astragaloside IV (AST-IV) is a saponin isolated from Astragalus membranaceus (AM).
View Article and Find Full Text PDFMechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment.
Biomed Pharmacother
September 2023
People's Hospital of Ningxiang City, Ningxiang, Hunan, China.
Acute myocardial infarction remains the leading cause of death in humans. Timely restoration of blood perfusion to ischemic myocardium remains the most effective strategy in the treatment of acute myocardial infarction, which can significantly reduce morbidity and mortality. However, after restoration of blood flow and reperfusion, myocardial injury will aggravate and induce apoptosis of cardiomyocytes, a process called myocardial ischemia-reperfusion injury.
View Article and Find Full Text PDFCorrection: Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
J Exp Clin Cancer Res
March 2023
Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!